| 1 |
Katz PO, Gerson LB, Vela MF.Guidelines for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2013, 108(3): 308-328.
|
| 2 |
El-Serag HB, Sweet S, Winchester CC, et al.Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
|
| 3 |
Shaheen N, Ransohoff DF.Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review[J]. JAMA, 2002, 287(15): 1972-1981.
|
| 4 |
Zhang D, Zhou J, Chen B, et al.Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis[J]. Acta Otolaryngologica, 2014, 134(10): 982-989.
|
| 5 |
Langevin SM, Michaud DS, Marsit CJ, et al.Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(6): 1061-1068.
|
| 6 |
陈旻湖，侯晓华，肖英连，等．2014年中国胃食管反流病专家共识意见[J]．中华消化杂志，2014，34(10)：649-656.
|
| 7 |
Abd El-Rehim DM, Fath El-Bab HK, Kamal EM.Expression of proteinase-activated receptor-2 in the esophageal mucosa of gastroesophageal reflux disease patients: a histomorphologic and Immunohistochemical study[J]. Appl Immunohistochem Mol Morphol, 2014 Sep 26.Appl Immunohistochem Mol Morphol, 2014 Sep 26.
|
| 8 |
Chourasia D, Achyut BR, Tripathi S, et al.Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1(T1)haplotype may protect against the disease[J]. Am J Gastroenterol, 2009, 104(11): 2704-2713.
|
| 9 |
Vakil N, van Zanten SV, Kahrilas P, et al.The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8): 1900-1920.
|
| 10 |
Moayyedi P, Talley NJ, Fennerty MB, et al.Can the clinical history distinguish between organic and functional dyspepsia? [J]. JAMA, 2006, 295(13): 1566-1576.
|
| 11 |
Lenfant C. Chest pain of cardiac and noncardiac origin[J]. Metabolism, 2010, 59 Suppl 1: S41-46.
|
| 12 |
Lee AL, Button BM, Denehy L, et al.Exhaled Breath Condensate Pepsin: Potential Noninvasive Test for Gastroesophageal Reflux in COPD and Bronchiectasis[J]. Respir Care, 2015, 60(2): 244-250.
|
| 13 |
Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease[J]. Aliment Pharmacol Ther, 2010, 32(3): 334-343.
|
| 14 |
Franzen T, Grahn LT.Reliability of 24-hour oesophageal pH monitoring under standardized conditions[J]. Scand J Gastroenterol, 2002, 37(1): 6-8.
|
| 15 |
Yang XJ, Gan T, Wang L, et al.Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: A multicenter clinical study[J]. World J Gastroenterol, 2014, 20(40): 14865-14874.
|
| 16 |
Han MS, Lada MJ, Nieman PR, et al.24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms[J]. Surg Endosc, 2015, 29(7): 1700-1708..
|
| 17 |
Sifrim D, Castell D, Dent J, et al.Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux[J]. Gut, 2004, 53(7): 1024-1031.
|
| 18 |
Zhou L, Wang Y, Lu JJ, et al.Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology[J]. J Dig Dis, 2014, 15(5): 230-238.
|
| 19 |
Frazzoni M, Conigliaro R, Mirante VG, et al.The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn[J]. Neurogastroenterol Motil, 2012, 24(2): 141-146, e87.
|
| 20 |
Kohata Y , Fujiwara Y, Machida H, et al.Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring[J]. J Gastroenterol Hepatol, 2012, 27 Suppl 3: 58-62.
|
| 21 |
Mazzoleni G, Vailati C, Lisma DG, et al.Correlation between oropharyngeal pH-monitoring and esophageal pH-impedance monitoring in patients with suspected GERD-related extra-esophageal symptoms[J]. Neurogastroenterol Motil, 2014, 26(11): 1557-1564.
|
| 22 |
Bredenoord AJ, Fox M, Kahrilas PJ, et al.Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography[J]. Neurogastroenterol Motil, 2012, 24 Suppl 1: 57-65.
|
| 23 |
Hashmi S, Rao SS, Srmrners RW, et al.esophageal pressure topography, body position, and hiatal hernia[J]. J Clin Gastroenterol, 2014, 48(3): 224-230.
|
| 24 |
Kwiatek MA, Pandolfino JE, Hirano I, et al.Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe(EndoFLIP)[J]. Gastrointest Endosc, 2010, 72(2): 272-278.
|
| 25 |
Ilczyszyn A, Botha AJ.Feasibility of esophagogastric junction distensibility measurement during Nissen fundoplication[J]. Dis Esophagus, 2014, 27(7): 637-644.
|
| 26 |
Familiari P, Gigante G, Marchese M, et al.EndoFLIP system for the intraoperative evaluation of peroral endoscopic myotomy[J]. United European Gastroenterol J, 2014, 2(2): 77-83.
|